Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Penumbra Inc PEN

Healthcare Medical Devices
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on... see more

Recent & Breaking News (NYSE:PEN)

Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference

PR Newswire 5 days ago

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

PR Newswire 13 days ago

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

PR Newswire April 9, 2024

Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire February 22, 2024

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024

PR Newswire February 1, 2024

Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference

PR Newswire December 18, 2023

First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash(TM) - for Treatment of Acute Pulmonary Embolism

PR Newswire November 28, 2023

Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

PR Newswire November 14, 2023

Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans

PR Newswire November 10, 2023

Penumbra, Inc. Reports Third Quarter 2023 Financial Results

PR Newswire November 2, 2023

NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA'S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMES

PR Newswire November 1, 2023

Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023

PR Newswire October 5, 2023

Penumbra, Inc. to Present at Upcoming Investor Conferences

PR Newswire August 23, 2023

Penumbra, Inc. Reports Second Quarter 2023 Financial Results

PR Newswire August 1, 2023

Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference

PR Newswire July 26, 2023

Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023

PR Newswire July 5, 2023

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

PR Newswire June 1, 2023

Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference

PR Newswire May 24, 2023

Penumbra, Inc. Reports First Quarter 2023 Financial Results

PR Newswire May 2, 2023

Penumbra, Inc. to Present at Upcoming Investor Conferences

PR Newswire April 25, 2023